Clinical Trial Update: Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating autologous bone marrow mononuclear cell therapy for diabetic lower limb ischemia; the trial is sponsored by Hebei Medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Peripheral Arterial Disease

Drugs mentioned

• Autologous bone marrow mononuclear cell therapy (bone marrow mononuclear cells)

Snippet

Sponsor: Hebei Medical University | Conditions: Diabetes, Lower Limb Ischemia | Phase 1 | Status: UNKNOWN